Ibruxen (Ibrutinib) 140mg

Ibruxen 140mg Capsules contain Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor that blocks signals involved in the growth and survival of certain cancer cells. Key Information

• Active Ingredient: Ibrutinib 140mg
• Therapeutic Class: Bruton's tyrosine kinase (BTK) inhibitor
• Uses: Used for certain cases of mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, Waldenström macroglobulinemia, marginal zone lymphoma and chronic graft-versus-host disease.
• Administration: Taken orally as directed by a qualified healthcare professional. Capsules should be swallowed whole.
• Common Side Effects: Diarrhea, fatigue, muscle or joint pain, rash and bruising may occur.
• Important: Ibrutinib may cause serious bleeding, infections, heart problems and high blood pressure. Drug interactions are possible, so inform your healthcare professional about other medicines you take.

Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Consult a qualified healthcare professional before starting or changing any medication.